X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (789) 789
Publication (83) 83
Web Resource (33) 33
Newspaper Article (17) 17
Book / eBook (7) 7
Book Chapter (4) 4
Book Review (3) 3
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (247) 247
index medicus (223) 223
hematology (177) 177
oncology (146) 146
female (144) 144
male (142) 142
middle aged (138) 138
aged (136) 136
myelodysplastic syndromes (98) 98
adult (93) 93
leukemia (90) 90
cancer (78) 78
aged, 80 and over (75) 75
treatment outcome (75) 75
prognosis (72) 72
acute myeloid-leukemia (63) 63
myelodysplastic syndromes - drug therapy (62) 62
risk factors (55) 55
myelodysplastic syndromes - genetics (53) 53
abridged index medicus (50) 50
mutation (48) 48
mds (45) 45
scoring system (45) 45
survival (45) 45
hematology, oncology and palliative medicine (39) 39
chemotherapy (38) 38
azacitidine (36) 36
myelodysplastic syndromes - diagnosis (36) 36
care and treatment (35) 35
mutations (35) 35
myelodysplastic syndrome (34) 34
patients (34) 34
article (33) 33
myelodysplastic syndromes - pathology (32) 32
bone marrow (31) 31
myelodysplastic syndromes - mortality (31) 31
research (31) 31
young adult (31) 31
adolescent (30) 30
leukemia, myeloid, acute - drug therapy (30) 30
myelodysplastic syndromes - therapy (30) 30
antineoplastic agents - therapeutic use (29) 29
acute myeloid leukemia (28) 28
lenalidomide (27) 27
survival analysis (27) 27
classification (26) 26
decitabine (26) 26
leukemia, myeloid, acute - genetics (26) 26
remission induction (26) 26
transplantation (26) 26
hemic and lymphatic diseases (25) 25
retrospective studies (25) 25
survival rate (25) 25
therapy (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
leukemia, myeloid, acute - mortality (23) 23
phase-iii (22) 22
risk (22) 22
azacitidine - analogs & derivatives (21) 21
antimetabolites, antineoplastic - therapeutic use (20) 20
diagnosis (20) 20
disease progression (20) 20
thalidomide - analogs & derivatives (20) 20
acute myelogenous leukemia (19) 19
aml (19) 19
azacitidine - therapeutic use (19) 19
colony-stimulating factor (19) 19
cytarabine - administration & dosage (19) 19
disease-free survival (19) 19
efficacy (19) 19
international working group (19) 19
response criteria (19) 19
analysis (18) 18
myeloid neoplasia (18) 18
prognostic scoring system (18) 18
cytogenetics (17) 17
medical research (17) 17
thalidomide - therapeutic use (17) 17
chromosome aberrations (16) 16
genetic aspects (16) 16
hematopoietic stem cell transplantation (16) 16
patient outcomes (16) 16
chromosome deletion (15) 15
cohort studies (15) 15
impact (15) 15
leukemia, myeloid, acute - pathology (15) 15
world-health-organization (15) 15
age factors (14) 14
azacitidine - administration & dosage (14) 14
clinical trials (14) 14
older patients (14) 14
polymorphism, single nucleotide (14) 14
recurrence (14) 14
animals (13) 13
chronic myelomonocytic leukemia (13) 13
drug administration schedule (13) 13
follow-up studies (13) 13
hematopoietic stem cells (13) 13
karyotyping (13) 13
leukemia, myeloid, acute - diagnosis (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2017, Fifth edition., ISBN 9781119196204, 1299
The fifth edition of the only comprehensive text dealing exclusively with rare or infrequently encountered malignancies in adults and children is an essential... 
Rare Diseases | Neoplasms | Tumors
Book
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 13, pp. 1374 - 1375
Journal Article
Leukemia, ISSN 0887-6924, 03/2019, Volume 33, Issue 3, pp. 570 - 575
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 25, pp. 2956 - 2957
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 13, pp. 1374 - 1374
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 01/2017, Volume 68, p. 127
  Precision medicine can be simply defined as the identification of personalized treatment that matches patient-specific clinical and genomic characteristics.... 
Proteins | Genomics | Medical treatment | Leukemia | Mutation
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 01/2017, Volume 68, pp. 127 - 127
Precision medicine can be simply defined as the identification of personalized treatment that matches patient-specific clinical and genomic characteristics.... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1824 - 1824
Abstract Morphology has dominated the diagnosis and classification of MDS for decades. With the advent of NGS, morphology is used as a gold standard to assess... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2590 - 2590
Abstract Based on clinical Camitta criteria, acquired aplastic anemia is categorized according to the degree of blood count depression as severe (sAA) or... 
Journal Article
Best Practice & Research Clinical Haematology, ISSN 1521-6926, 12/2018, Volume 31, Issue 4, pp. 346 - 350
Therapies for myelodysplastic syndromes (MDS) are chosen depending on whether a patient has lower- or higher-risk disease. Hypomethylating agents are... 
MDS | Hypomethylating agents | Myelodysplastic syndromes | Transplant | LOW-DOSE DECITABINE | ACUTE MYELOID-LEUKEMIA | AZACITIDINE | CHEMOTHERAPY | CARE | LOW-RISK | SCORING SYSTEM | INTERGROUP | HEMATOLOGY | Chemotherapy | Transplantation | Hematopoietic stem cells | Cancer
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2298 - 2298
Abstract Background The development of therapy-related AML (t-AML) is a rare but fatal complication of cancer therapies, with varying leukemogenicity... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Suppl_1, pp. 4374 - 4374
Abstract Background: Only a minority of patients diagnosed with myelodysplastic syndromes (MDS) enroll in interventional clinical trials, which impedes... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2583 - 2583
Abstract Next generation sequencing (NGS) methods, including whole exome sequencing (WES) and sequencing of large panels of genes have become standard tools... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.